249 related articles for article (PubMed ID: 28272234)
21. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure.
Takihara Y; Inatani M; Fukushima M; Iwao K; Iwao M; Tanihara H
Am J Ophthalmol; 2009 May; 147(5):912-8, 918.e1. PubMed ID: 19195639
[TBL] [Abstract][Full Text] [Related]
22. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
23. [Effects of vitrectomy as a treatment for proliferative diabetic retinopathy in young patients].
Usui A; Kiyokawa M; Kimura I; Sakuma T; Ito R; Hatano N; Mizota A; Tanaka M
Nippon Ganka Gakkai Zasshi; 2011 Jun; 115(6):516-22. PubMed ID: 21735755
[TBL] [Abstract][Full Text] [Related]
24. Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage.
Li XJ; Yang XP; Li QM; Wang YY; Lyu XB
Chin Med J (Engl); 2015 Aug; 128(15):2078-83. PubMed ID: 26228222
[TBL] [Abstract][Full Text] [Related]
25. Risk factors for requirement of filtration surgery after vitrectomy in patients with proliferative diabetic retinopathy.
Sakamoto M; Hashimoto R; Yoshida I; Maeno T
Clin Ophthalmol; 2018; 12():733-738. PubMed ID: 29713141
[TBL] [Abstract][Full Text] [Related]
26. Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients.
Liao M; Wang X; Yu J; Meng X; Liu Y; Dong X; Li J; Brant R; Huang B; Yan H
BMC Ophthalmol; 2020 Oct; 20(1):416. PubMed ID: 33076873
[TBL] [Abstract][Full Text] [Related]
27. Effect of intravitreal ranibizumab pretreatment on vitrectomy in young patients with proliferative diabetic retinopathy.
Chen HJ; Wang CG; Dou HL; Feng XF; Xu YM; Ma ZZ
Ann Palliat Med; 2020 Jan; 9(1):82-89. PubMed ID: 32005066
[TBL] [Abstract][Full Text] [Related]
28. Surgical Treatment of Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy in Japanese Patients without the Use of Glaucoma Drainage Devices.
Takeuchi M; Kanda T; Harimoto K; Sora D; Okazawa R; Sato T
J Clin Med; 2024 May; 13(11):. PubMed ID: 38892963
[No Abstract] [Full Text] [Related]
29. Evaluation of EX-PRESS glaucoma implant in elderly diabetic patients after 23G vitrectomy.
Lyssek-Boroń A; Wylęgała A; Dobrowolski D; Kowalczyk E; Polanowska K; Wylęgała E
Clin Interv Aging; 2017; 12():653-658. PubMed ID: 28435237
[TBL] [Abstract][Full Text] [Related]
30. Potential bias of preoperative intravitreal anti-VEGF injection for complications of proliferative diabetic retinopathy.
Takayama K; Someya H; Yokoyama H; Kimura T; Takamura Y; Morioka M; Terasaki H; Ueda T; Ogata N; Kitano S; Tashiro M; Sakamoto T; Takeuchi M
PLoS One; 2021; 16(10):e0258415. PubMed ID: 34624063
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal bevacizumab for postoperative recurrent vitreous hemorrhage after vitrectomy for proliferative diabetic retinopathy.
Ferenchak K; Duval R; Cohen JA; MacCumber MW
Retina; 2014 Jun; 34(6):1177-81. PubMed ID: 24457977
[TBL] [Abstract][Full Text] [Related]
32. Visual Outcomes in Eyes With Neovascular Glaucoma and Anterior Segment Neovascularization Without Glaucoma.
Sastry A; Ryu C; Jiang X; Ameri H
Am J Ophthalmol; 2022 Apr; 236():1-11. PubMed ID: 34562418
[TBL] [Abstract][Full Text] [Related]
33. Combined vitrectomy, near-confluent panretinal endolaser, bevacizumab and cyclophotocoagulation for neovascular glaucoma - a retrospective interventional case series.
Strzalkowski P; Strzalkowska A; Göbel W; Loewen NA; Hillenkamp J
F1000Res; 2020; 9():1236. PubMed ID: 33796275
[No Abstract] [Full Text] [Related]
34. Photocoagulation Up to Ora Serrata in Diabetic Vitrectomy to Prevent Recurrent Vitreous Hemorrhage.
Yoon CY; Shin MC; Kim P; Shin YK; Kim WJ
Korean J Ophthalmol; 2023 Dec; 37(6):477-484. PubMed ID: 37899285
[TBL] [Abstract][Full Text] [Related]
35. Ahmed Valves vs Trabeculectomy Combined with Pans Plana Vitrectomy for Neovascular Glaucoma with Vitreous Hemorrhage.
Wang MH; Li QM; Dong HT; Dong SQ; Li Y; Zheng CY
Eur J Ophthalmol; 2017 Nov; 27(6):774-780. PubMed ID: 28430329
[TBL] [Abstract][Full Text] [Related]
36. Reasons for and management of postvitrectomy vitreous hemorrhage in proliferative diabetic retinopathy.
Yan H; Cui J; Lu Y; Yu J; Chen S; Xu Y
Curr Eye Res; 2010 Apr; 35(4):308-13. PubMed ID: 20373898
[TBL] [Abstract][Full Text] [Related]
37. [Simultaneous pars plana vitrectomy and glaucoma drainage device implant].
Suárez-Fernández MJ; Gutiérrez-Díaz E; Julve San Martín A; Fernández-Reyes MF; Mencía-Gutiérrez E
Arch Soc Esp Oftalmol; 2010 Mar; 85(3):97-102. PubMed ID: 20619120
[TBL] [Abstract][Full Text] [Related]
38. Reoperation following vitrectomy for diabetic vitreous hemorrhage with versus without preoperative intravitreal bevacizumab.
Hu X; Pan Q; Zheng J; Song Z; Zhang Z
BMC Ophthalmol; 2019 Sep; 19(1):200. PubMed ID: 31519158
[TBL] [Abstract][Full Text] [Related]
39. Intravitreal bevacizumab for prevention of early postvitrectomy hemorrhage in diabetic patients: a randomized clinical trial.
Ahmadieh H; Shoeibi N; Entezari M; Monshizadeh R
Ophthalmology; 2009 Oct; 116(10):1943-8. PubMed ID: 19699531
[TBL] [Abstract][Full Text] [Related]
40. Microincision vitrectomy surgery and intravitreal bevacizumab as a surgical adjunct to treat diabetic traction retinal detachment.
Oshima Y; Shima C; Wakabayashi T; Kusaka S; Shiraga F; Ohji M; Tano Y
Ophthalmology; 2009 May; 116(5):927-38. PubMed ID: 19269033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
